The Acheivement’s of Proove Bio

News and Media

March 23, 2017 – Proove Release: Proove CEO to Speak at 8 th Annual Life Sciences CEO Forum

Brian Meshkin will moderate a panel on "Delivering on the Promise of Precision Medicine" and participate in a panel on "The Convergence of Technology & Healthcare" IRVINE, Calif., March 23, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and...

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...

December 7, 2016 – Proove Release: Proove Launches First Precision Medicine Test for TMJ Disorder

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain IRVINE, CA--(Marketwired - Dec 7, 2016) - Proove Biosciences, Inc., the...

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

Study Shows Over 90% of Patients Experienced Significant Pain Reduction without Opioid Abuse and Physicians Believe Technology Provides Patient Benefits to Help Reduce Opioid Epidemic IRVINE, Calif., June 21, 2017 /PRNewswire/ -- Proove® Biosciences,...

May 4, 2016 – Proove Release: Proove Announces Collaboration with McGill University

New Agreement Creates Collaborative Framework for Commercializing Laboratory Research to Help Pain Patients Irvine, CA (PRWEB) May 04, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce a strategic...

April 19, 2017 – Proove Release: First Published Study of Precision Medicine to Predict Opioid Abuse

Results Published in the Journal Pharmacogenomics and Personalized Medicine Shows Proove Opioid Risk® Accurately Identifies Prescription Opioid Abuse Risk IRVINE, Calif., April 19, 2017 /PRNewswire/ -- As a Bronze Sponsor of the National Rx Drug Abuse and Heroin...

March 30, 2016 – Proove Release: Proove Expands Sales Force

IRVINE, CA (PRWEB) MARCH 30, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized...

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

Results Published in the Journal of Addiction Research and Therapy Shows Nearly 97% Accuracy in Identifying Patients At-Risk of Prescription Opioid Abuse IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces a new study validating the...

Video’s

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Get Instant Access to Updates to The Truth about Proove Bio